BFM
ASMB icon

Boothbay Fund Management’s Assembly Biosciences ASMB Stock Holding History

Boothbay Fund Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21
Closed -$374K – 958
2020
Q1 		$374K Hold
21
– – 0.03% 511
2019
Q4 		$516K Buy
+21
New +$3.87K 0.04% 479

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's ASMB Position: Q2 2022 in Review

Boothbay Fund Management sold out of Assembly Biosciences (ASMB) in Q2 2022, closing a stake of 1,784 shares — an estimated $44K sold.

Boothbay Fund Management first reported a position in ASMB in Q2 2019 and held it in 12 quarters. The position peaked at $2.59M in Q4 2019. 54 funds tracked by Wall St. Rank hold ASMB as of Q2 2022.

  • Boothbay Fund Management reported no remaining Assembly Biosciences position as of Q2 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 1,784 Assembly Biosciences shares in Q2 2022, an estimated $44K.
  • Boothbay Fund Management first reported a position in Assembly Biosciences in Q2 2019 and held it in 12 quarters.
  • Boothbay Fund Management's Assembly Biosciences position peaked at $2.59M in Q4 2019.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.